The epidemic of allergy and asthma

[1]  C. Plopper,et al.  The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. , 1999, American journal of respiratory cell and molecular biology.

[2]  K. Chung,et al.  Cytokines in asthma , 1999, Thorax.

[3]  S. Holgate,et al.  The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. , 1999, Allergy.

[4]  P. Kalinski,et al.  The paradigm of type 1 and type 2 antigen‐presenting cells. Implications for atopic allergy , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  P. O'Byrne,et al.  Interaction between haemopoietic regulation and airway inflammation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  S. Holgate,et al.  Regulation of pulmonary T cell responses to inhaled antigen: role in Th1- and Th2-mediated inflammation. , 1999, Journal of immunology.

[7]  K. Dabbagh,et al.  IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. , 1999, Journal of immunology.

[8]  H. Sewell,et al.  The interaction between the dust mite antigen Der p 1 and cell‐signalling molecules in amplifying allergic disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[10]  E. Israel,et al.  Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. , 1999, The New England journal of medicine.

[11]  J. Peat,et al.  Reversing the trend: reducing the prevalence of asthma. , 1999, The Journal of allergy and clinical immunology.

[12]  A. Kay,et al.  Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma , 1998, The Lancet.

[13]  Jones,et al.  Intrauterine environment and fetal allergic sensitization , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  Richard Beasley,et al.  Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC , 1998, The Lancet.

[15]  S. Holgate,et al.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. , 1998, The Journal of clinical investigation.

[16]  D. Mattey,et al.  Transforming growth factor β1 and interleukin 4 induced α smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor , 1997 .

[17]  N. Kalsheker,et al.  On the potential significance of the enzymatic activity of mite allergens to immunogenicity. Clues to structure and function revealed by molecular characterization , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  M. Sears.  RESPIRATORY DISEASE Transplantation asthma , 1993, The Lancet.

[19]  P. Corris,et al.  Aetiology of asthma: lessons from lung transplantation , 1993, The Lancet.

[20]  W. Owen,et al.  Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. , 1991, The Journal of clinical investigation.